The development of live attenuated cold-adapted influenza virus vaccine for humans

Reviews in Medical Virology

Volumn 9, Issue 4, 1999, Pages 237-244

  Maassab, Hunein F ^a   Bryant, Martin L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; MEMBRANE ANTIGEN; VIRUS GLYCOPROTEIN;

CELLULAR IMMUNITY; DRUG EFFICACY; DRUG SAFETY; GENETIC STABILITY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTRANASAL DRUG ADMINISTRATION; REVIEW; TEMPERATURE; VACCINE PRODUCTION; VIRAL GENETICS; VIROGENESIS; VIRUS MUTANT; VIRUS TRANSMISSION;

ADAPTATION, PHYSIOLOGICAL; COLD; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, ATTENUATED;

EID: 0032748256     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G     Document Type: Review

References (5)

1. Thomson, D. and Thomson, R. (1934). Influenza with special reference to the complications and sequelae, bacteriology of influenzae pneumonia, pathology, epidemiological data, prevention and treatment. Ann Pickett-Thomson Res. Lab. 10, 641-677.
2. Francis, T. Jr, Quilligan, J. J. Jr and Minuse, E. (1950). Identification of another epidemic respiratory disease. Science 112, 495-497.
3. Stuart-Harris, Sir Charles and Shild, G. C. (1976). Influenza: The Viruses and the Disease. Publishing Sciences Group Inc.: Littleton, Mass.
4. Francis, T. F., Jr. (1945) Influenza: Methods of study and control. Bull. NY Acad Med. 2, 337-355.
5. Glezen. W. P. (1982). Serious morbidity and mortality associated with influenza epidemics. Epidemiol. Rev. 4, 25-44.